The S troke H yperglycemia I nsulin N etwork E ffort ( SHINE ) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke

Show simple item record

dc.contributor.author Bruno, Askiel en_US
dc.contributor.author Durkalski, Valerie L. en_US
dc.contributor.author Hall, Christiana E. en_US
dc.contributor.author Juneja, Rattan en_US
dc.contributor.author Barsan, William G. en_US
dc.contributor.author Janis, Scott en_US
dc.contributor.author Meurer, William J. en_US
dc.contributor.author Fansler, Amy en_US
dc.contributor.author Johnston, Karen C. en_US
dc.date.accessioned 2014-02-11T17:57:25Z
dc.date.available 2015-04-01T19:59:07Z en_US
dc.date.issued 2014-02 en_US
dc.identifier.citation Bruno, Askiel; Durkalski, Valerie L.; Hall, Christiana E.; Juneja, Rattan; Barsan, William G.; Janis, Scott; Meurer, William J.; Fansler, Amy; Johnston, Karen C. (2014). "The S troke H yperglycemia I nsulin N etwork E ffort ( SHINE ) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke." International Journal of Stroke (2): 246-251. en_US
dc.identifier.issn 1747-4930 en_US
dc.identifier.issn 1747-4949 en_US
dc.identifier.uri http://hdl.handle.net/2027.42/102726
dc.publisher Wiley en_US
dc.subject.other Protocols en_US
dc.subject.other Hyperglycemia en_US
dc.subject.other Clinical Trial en_US
dc.subject.other Cerebral Infarction en_US
dc.subject.other Acute Ischemic Stroke en_US
dc.title The S troke H yperglycemia I nsulin N etwork E ffort ( SHINE ) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke en_US
dc.type Article en_US
dc.rights.robots IndexNoFollow en_US
dc.subject.hlbsecondlevel Neurosciences en_US
dc.subject.hlbtoplevel Health Sciences en_US
dc.description.peerreviewed Peer Reviewed en_US
dc.description.bitstreamurl http://deepblue.lib.umich.edu/bitstream/2027.42/102726/1/ijs12045.pdf
dc.identifier.doi 10.1111/ijs.12045 en_US
dc.identifier.source International Journal of Stroke en_US
dc.identifier.citedreference Wong AA, Schluter PJ, Henderson RD, O'Sullivan JD, Read SJ. Natural history of blood glucose within the first 48 hours after ischemic stroke. Neurology 2008; 70: 1036 – 1041. en_US
dc.identifier.citedreference de Courten‐Myers GM, Kleinholz M, Wagner KR, Myers RE. Normoglycemia (not hypoglycemia) optimizes outcome from middle cerebral artery occlusion. J Cereb Blood Flow Metab 1994; 14: 227 – 236. en_US
dc.identifier.citedreference Meden P, Andersen M, Overgaard K, Rasmussen RS, Boysen G. The effects of early insulin treatment combined with thrombolysis in rat embolic stroke. Neurol Res 2002; 24: 399 – 404. en_US
dc.identifier.citedreference Zhu CZ, Auer RN. Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J Neurosurg 2004; 101: 664 – 668. en_US
dc.identifier.citedreference Ntaios G, Egli M, Faouzi M, Michel P. J‐shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke 2010; 41: 2366 – 2370. en_US
dc.identifier.citedreference Malmberg K, Ryden L, Efendic S et al. Randomized trial of insulin‐glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57 – 65. en_US
dc.identifier.citedreference Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449 – 461. en_US
dc.identifier.citedreference Bruno A, Kent TA, Coull BM et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke 2008; 39: 384 – 389. en_US
dc.identifier.citedreference Johnston KC, Hall CE, Kissela BM, Bleck TP, Conaway MR. Glucose regulation in acute stroke patients (GRASP) trial: a randomized pilot trial. Stroke 2009; 40: 3804 – 3809. en_US
dc.identifier.citedreference Adams HP Jr, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655 – 1711. en_US
dc.identifier.citedreference Gray CS, Hildreth AJ, Sandercock PA et al. Glucose‐potassium‐insulin infusions in the management of post‐stroke hyperglycaemia: the UK glucose insulin in stroke trial (GIST‐UK). Lancet Neurol 2007; 6: 397 – 406. en_US
dc.identifier.citedreference Kreisel SH, Berschin UM, Hammes HP et al. Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment. Cerebrovasc Dis 2009; 27: 167 – 175. en_US
dc.identifier.citedreference Walters MR, Weir CJ, Lees KR. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis 2006; 22: 116 – 122. en_US
dc.identifier.citedreference Adams HP, Jr, Leclerc JR, Bluhmki E, Clarke W, Hansen MD, Hacke W. Measuring outcomes as a function of baseline severity of ischemic stroke. Cerebrovasc Dis 2004; 18: 124 – 129. en_US
dc.identifier.citedreference Adams HP, Jr, Effron MB, Torner J et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: abciximab in emergency treatment of stroke trial (AbESTT‐II). Stroke 2008; 39: 87 – 99. en_US
dc.identifier.citedreference Bruno A, Waddell MJ, Potter DJ et al. Opportunity to lower hyperglycaemia faster in patients with acute ischaemic stroke and diabetes. Int J Stroke 2010; 5: 338 – 339. en_US
dc.identifier.citedreference Zhao W, Hill MD, Palesch Y. Minimal sufficient balance – a new strategy to balance baseline covariates and preserve randomness of treatment allocation. Stat Methods Med Res 2012, doi: 10.1177/0962280212436447. en_US
dc.identifier.citedreference Hu F, Rosenberger WF. The Theory of Response Adaptive Randomization in Clinical Trials. New York, Wiley, 2006. en_US
dc.identifier.citedreference Juneja R, Roudebush C, Kumar N et al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther 2007; 9: 232 – 240. en_US
dc.identifier.citedreference Towler DA, Havlin CE, Craft S, Cryer P. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 1993; 42: 1791 – 1798. en_US
dc.identifier.citedreference Williams LS, Weinberger M, Harris LE, Biller J. Measuring quality of life in a way that is meaningful to stroke patients. Neurology 1999; 53: 1839 – 1843. en_US
dc.identifier.citedreference The National Institute of Neurological Disorders and Stroke rt‐PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581 – 1587. en_US
dc.identifier.citedreference Palesch YY, Hill MD, Ryckborst KJ, Tamariz D, Ginsberg MD. The ALIAS pilot trial: a dose‐escalation and safety study of albumin therapy for acute ischemic stroke – II: neurologic outcome and efficacy analysis. Stroke 2006; 37: 2107 – 2114. en_US
dc.identifier.citedreference Gould AL, Shih WJ. Modifying the design of ongoing trials without unblinding. Stat Med 1998; 17: 89 – 100. en_US
dc.identifier.citedreference O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549 – 556. en_US
dc.identifier.citedreference Lan KKG, Demets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70: 659 – 663. en_US
dc.identifier.citedreference Gentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med 2006; 13: 174 – 180. en_US
dc.identifier.citedreference Williams LS, Rotich J, Qi R et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002; 59: 67 – 71. en_US
dc.identifier.citedreference Kruyt ND, Biessels GJ, Devries JH, Roos YB. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol 2010; 6: 145 – 155. en_US
dc.owningcollname Interdisciplinary and Peer-Reviewed
 Show simple item record

This item appears in the following Collection(s)


Search Deep Blue

Advanced Search

Browse by

My Account

Information

Available Now


MLibrary logo